Get started
Author

Suzanne Paz

Observed names: S Paz, S. Paz
ORCID: 0000-0003-4110-5696
Observed ORCID: 0000-0003-4110-5696
OpenAlex ID: A5033398235
Inhibition of VEGF binding to neuropilin-2 enhances chemosensitivity and inhibits metastasis in triple-negative breast cancer
2023 · Zhiwen Xu, Hira Lal Goel, et al. · Science Translational Medicine · 49
PDF
Underlying Immune Disorder May Predispose Some Transthyretin Amyloidosis Subjects to Inotersen-Mediated Thrombocytopenia
2020 · Padmakumar Narayanan, Brian R. Curtis, et al. · Nucleic Acid Therapeutics · 29
The Distinct and Cooperative Roles of Toll-Like Receptor 9 and Receptor for Advanced Glycation End Products in Modulating In Vivo Inflammatory Responses to Select CpG and Non-CpG Oligonucleotides
2017 · Suzanne Paz, Jill Hsiao, et al. · Nucleic Acid Therapeutics · 28
Efzofitimod: a novel anti-inflammatory agent for sarcoidosis.
2023 · Robert P Baughman, Vis Niranjan, et al. · Sarcoidosis vasculitis and diffuse lung diseases · 24
PDF
Inflammatory Non-CpG Antisense Oligonucleotides Are Signaling Through TLR9 in Human Burkitt Lymphoma B Bjab Cells
2022 · Adam J. Pollak, Patrick Cauntay, et al. · Nucleic Acid Therapeutics · 24
PDF
Early-Stage Identification and Avoidance of Antisense Oligonucleotides Causing Species-Specific Inflammatory Responses in Human Volunteer Peripheral Blood Mononuclear Cells
2022 · Sebastien A. Burel, Todd Machemer, et al. · Nucleic Acid Therapeutics · 22
PDF
A human histidyl-tRNA synthetase splice variant therapeutic targets NRP2 to resolve lung inflammation and fibrosis
2025 · Leslie A. Nangle, Zhiwen Xu, et al. · Science Translational Medicine · 16
Neuropilin-2, the Specific Binding Partner to ATYR1923, Is Expressed in Sarcoid Granulomas and Key Immune Cells
2020 · S. Paz, D. Chu, et al. · American Journal of Respiratory and Critical Care Medicine · 5
ATYR1923 Modulates the Inflammatory Response in Experimental Models of Interstitial Lung Disease
2019 · C. Burkart, M. Seikkula, et al. · American Journal of Respiratory and Critical Care Medicine · 5
Late Breaking Abstract - Immunomodulatory protein ATYR1923 disrupts an in vitro model of sarcoid granuloma formation
2021 · Suzanne Paz, Mark W. Julian, et al. · European Respiratory Journal · 4
ATYR1923 Specifically Binds to Neuropilin-2, a Novel Therapeutic Target for the Treatment of Immune-Mediated Diseases
2020 · Z. Xu, Y. Chong, et al. · American Journal of Respiratory and Critical Care Medicine · 2
A novel neuropilin-2 (NRP2) antibody for immunohistochemical staining of patient tissue samples
2022 · Y Chong, S Förster, et al. · European Respiratory Journal · 1
699 ATYR2810 an anti-NRP2 monoclonal antibody targets tumor-associated macrophages
2021 · Samantha Tyler, Michaela Ferrer, et al. · Journal for ImmunoTherapy of Cancer · 1
PDF
Efzofitimod, a Novel Immunomodulator for Pulmonary Sarcoidosis, Modulates Patient Inflammatory Responses Through Myeloid Cells
2023 · D. Siefker, S. Paz, et al. · American Journal of Respiratory and Critical Care Medicine
Abstract LB085: ATYR2810, a fully humanized monoclonal antibody targeting the VEGF-NRP2 pathway sensitizes highly aggressive and chemoresistant TNBC subtypes to chemotherapy
2022 · Zhiwen Xu, Alison Barber, et al. · Cancer Research
Works count: 15
Citation count: 210
H-index: 7
I10-index: 7
Year
Topic
Type